Judge rejects Sanofi's request to prevent sales of a generic Lovenox

08/26/2010 | Bloomberg Businessweek

U.S. District Judge Emmet Sullivan denied a request by Sanofi-Aventis to prevent an FDA-approved copy of its blood thinner Lovenox from going into the market. The generic was developed by Novartis' Sandoz subsidiary and Momenta Pharmaceuticals. The judge said delaying the distribution of the generic could have a negative effect on the public.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX